ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

DCBD Board Approves Concepts For 43.5 Million In New Grants, $1.9 Million In Contract Supported Projects

November 13, 1981

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Research Opportunities On Diet, Nutrition Outlined To NCAB

July 11, 1975